Viral Vector Commercial cGMP Fill/Finish Services

Our standards are high, and our aseptic fill/finish services are comprehensive. Compliance is key. Our Cambridge and Lexington facilities and processes are designed to be compliant for viral vector-based gene therapy products under the FDA Code of Federal Regulations (Part 21) and the European Advanced Therapy Medicinal Products’ regulations.

Automated fillings solutions:

Available services:

Question? We’re Here to Help.

Please contact us to learn more about our viral vector late-phase and commercial services.

Learn more about our Viral Vector cGMP Fill/Finish Services.